References:

• Huntingtin processing in pathogenesis of Huntington disease.

  Qin ZH, Gu ZL.
  Acta Pharmacol Sin. 2004 Oct;25(10):1243-9.

• Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription.

  Kegel KB, Meloni AR, Yi Y, Kim YJ, Doyle E, Cuiffo BG, Sapp E, Wang Y, Qin ZH, Chen JD, Nevins JR, Aronin N, DiFiglia M.
  J Biol Chem. 2002 Mar 1;277(9):7466-76. Epub 2001 Dec 05.

• Interference by Huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.

  Nucifora FC Jr, Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M, Takahashi H, Tsuji S, Troncoso J, Dawson VL, Dawson TM, Ross CA.
  Science. 2001 Mar 23;291(5512):2423-8.

• Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes.

  Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, Conti L, Cataudella T, Leavitt BR, Hayden MR, Timmusk T, Rigamonti D, Cattaneo E.
  Nat Genet. 2003 Sep;35(1):76-83. Epub 2003 Jul 27.